retatrutide clinical trial information

retatrutide clinical trial information Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a A Study of Retatrutide (LY3437943)

Name: retatrutide clinical trial information Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a A Study of Retatrutide (LY3437943)
Brand: honicelindonesia.co.id
SKU: 90105930697
Price: 21.69 USD
Availability: InStock
Rating: 4.558 (11 reviews)

SKU: 90105930697

4.6

EUR21.69 EUR56.69

Pay in 4 interest-free payments of $5.42 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 13 - Oct 18

Description

The Phase 2 clinical trial, published in the New England Journal of Medicine, demonstrated remarkable outcomes

Borner, T., De Jonghe, B

Whether you choose medication, supplements, or a combination, the best outcome comes from personalized assessment, ongoing monitoring, and supporting the whole person (diet, activity, stress, sleep, digestion, nutrient status)

Unlocks access to GLP-1s, licensed providers, and ongoing care